Repare Therapeutics

-$0.51 (-5.63%) As of 1:58 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RPTX and other ETFs, options, and stocks.

About RPTX

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

CEO
Lloyd M. Segal
Employees
152
Headquarters
Saint-Laurent, Québec
Founded
2016

RPTX Key Statistics

Market cap
358.20M
Price-Earnings ratio
—
Dividend yield
—
Average volume
220.25K
High today
$8.83
Low today
$8.55
Open price
$8.82
Volume
6.74K
52 Week high
$35.75
52 Week low
$8.42

RPTX Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.86 per share
Actual
-$0.83 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure